Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, s... von Rizvi, Naiyer A, Dr, Mazières, Julien, Prof, Planchard, David, MD, Stinchcombe, Thomas E, MD, Dy, Grace K, MD, Antonia, Scott J, MD, Horn, Leora, MD, Lena, Hervé, MD, Minenza, Elisa, MD, Mennecier, Bertrand, MD, Otterson, Gregory A, MD, Campos, Luis T, MD, Gandara, David R, MD, Levy, Benjamin P, MD, Nair, Suresh G, MD, Zalcman, Gérard, Prof, Wolf, Jürgen, Prof, Souquet, Pierre-Jean, MD, Baldini, Editta, MD, Cappuzzo, Federico, MD, Chouaid, Christos, MD, Dowlati, Afshin, MD, Sanborn, Rachel, MD, Lopez-Chavez, Ariel, MD, Grohe, Christian, Prof, Huber, Rudolf M, Prof, Harbison, Christopher T, PhD, Baudelet, Christine, PhD, Lestini, Brian J, MD, Ramalingam, Suresh S, Prof

Volltext

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma von Domblides, Charlotte, Leroy, Karen, Monnet, Isabelle, Mazières, Julien, Barlesi, Fabrice, Gounant, Valérie, Baldacci, Simon, Mennecier, Bertrand, Toffart, Anne-Claire, Audigier-Valette, Clarisse, Doucet, Ludovic, Giroux-Leprieur, Etienne, Guisier, Florian, Ricordel, Charles, Molinier, Olivier, Perol, Maurice, Pichon, Eric, Robinet, Gilles, Templement-Grangerat, Dorine, Ruppert, Anne-Marie, Rabbe, Nathalie, Antoine, Martine, Wislez, Marie

Volltext

Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study von Mennecier, Bertrand, Khalifa, Jonathan, Descourt, Renaud, Greillier, Laurent, Naltet, Charles, Falchero, Lionel

Volltext

Immunotherapy and Interventional Radiology: Two Optimal Allies in the Management of Bronchial Cancer von Mennecier, Bertrand

Volltext

Ceritinib-related interstitial lung disease improving after treatment cessation without recurrence under either crizotinib or brigatinib: a case report von Bender, Laura, Meyer, Guillaume, Quoix, Elisabeth, Mennecier, Bertrand

Volltext

MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort von Beau-Faller, Michèle, Ruppert, Anne-Marie, Voegeli, Anne-Claire, Neuville, Agnès, Meyer, Nicolas, Guerin, Eric, Legrain, Michèle, Mennecier, Bertrand, Wihlm, Jean-Marie, Massard, Gilbert, Quoix, Elisabeth, Oudet, Pierre, Gaub, Marie P.

Volltext

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients von Prim, Nathalie, Legrain, Michele, Guerin, Eric, Mennecier, Bertrand, Weingertner, Noelle, Voegeli, Anne-Claire, Guenot, Dominique, Maugard, Christine M, Quoix, Anne-Elisabeth, Beau-Faller, Michele

Volltext

Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification von Weingertner, Noëlle, Meyer, Nicolas, Voegeli, Anne-Claire, Guenot, Dominique, Renaud, Stéphane, Massard, Gilbert, Falcoz, Pierre-Emmanuel, Olland, Anne, Mennecier, Bertrand, Gaub, Marie-Pierre, Lindner, Véronique, Ghnassia, Jean-Pierre, Quoix, Elisabeth, Chenard, Marie-Pierre, Beau-Faller, Michèle

Volltext

Diagnosis of Jejunal Metastases from Lung Cancer Using Capsule Endoscopy von Leduc, Charlotte, Prim, Nathalie, Mennecier, Bertrand, Delvaux, Michel, Gangi, Afshin, Quoix, Elisabeth

Volltext

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients von Emprou, Camille, Le Van Quyen, Pauline, Jégu, Jérémie, Prim, Nathalie, Weingertner, Noëlle, Guérin, Eric, Pencreach, Erwan, Legrain, Michèle, Voegeli, Anne‐Claire, Leduc, Charlotte, Mennecier, Bertrand, Falcoz, Pierre‐Emmanuel, Olland, Anne, Santelmo, Nicolas, Quoix, Elisabeth, Massard, Gilbert, Guenot, Dominique, Chenard, Marie‐Pierre, Beau‐Faller, Michèle

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer von Wakelee, Heather, Liberman, Moishe, Kato, Terufumi, Tsuboi, Masahiro, Lee, Se-Hoon, Gao, Shugeng, Chen, Ke-Neng, Dooms, Christophe, Majem, Margarita, Eigendorff, Ekkehard, Martinengo, Gastón L., Bylicki, Olivier, Rodríguez-Abreu, Delvys, Chaft, Jamie E., Novello, Silvia, Yang, Jing, Keller, Steven M., Samkari, Ayman, Spicer, Jonathan D.

Volltext

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer von Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A

Volltext

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation von Schaller, Alexandre, Beau-Faller, Michèle, Mennecier, Bertrand, Renaud-Picard, Benjamin, Weingertner, Noëlle, Massard, Gilbert, Quoix, Elisabeth

Volltext

Real-life experience of ceritinib in crizotinib-pretreated ALK + advanced non-small cell lung cancer patients von Cadranel, Jacques, Cortot, Alexis B, Lena, Hervé, Mennecier, Bertrand, Do, Pascal, Dansin, Eric, Mazieres, Julien, Chouaid, Christos, Perol, Maurice, Barlesi, Fabrice, Robinet, Gilles, Friard, Sylvie, Thiberville, Luc, Audigier-Valette, Clarisse, Vergnenegre, Alain, Westeel, Virginie, Slimane, Khemaies, Buturuga, Alexandru, Moro-Sibilot, Denis, Besse, Benjamin

Volltext

Re: Two centres’ experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinic... von Mennecier, Bertrand, Olland, Anne, Mascaux, Céline, Falcoz, Pierre-Emmanuel

Volltext

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study von Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, Hureaux, José, Veillon, Remi, Otto, Josiane, Madroszyk-Flandin, Anne, Cortot, Alexis, Guichard, François, Boudou-Rouquette, Pascaline, Langlais, Alexandra, Missy, Pascale, Morin, Franck, Moro-Sibilot, Denis

Volltext

Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort von Merveilleux du Vignaux, Claire, Dansin, Eric, Mhanna, Laurent, Greillier, Laurent, Pichon, Eric, Kerjouan, Mallorie, Clément-Duchêne, Christelle, Mennecier, Bertrand, Westeel, Virginie, Robert, Marie, Quantin, Xavier, Zalcman, Gérard, Thiberville, Luc, Lena, Hervé, Molina, Thierry, Calcagno, Fabien, Fournel, Pierre, Mazières, Julien, Besse, Benjamin, Girard, Nicolas

Volltext

Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort von Baldacci, Simon, Besse, Benjamin, Avrillon, Virginie, Mennecier, Bertrand, Mazieres, Julien, Dubray-Longeras, Pascale, Cortot, Alexis B., Descourt, Renaud, Doubre, Helene, Quantin, Xavier, Duruisseaux, Michael, Monnet, Isabelle, Moro-Sibilot, Denis, Cadranel, Jacques, Clément-Duchêne, Christelle, Cousin, Sophie, Ricordel, Charles, Merle, Patrick, Otto, Josiane, Schneider, Sophie, Langlais, Alexandra, Morin, Franck, Westeel, Virginie, Girard, Nicolas

Volltext

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation von Waterhouse, David M, Rothschild, Sacha, Dooms, Christophe, Mennecier, Bertrand, Bozorgmehr, Farastuk, Majem, Margarita, Heuvel, Michel H. van den, Linardou, Helena, Cho, Byoung Chul, Roberts-Thomson, Rachel, Tanaka, Kentaro, Blais, Normand, Schvartsman, Gustavo, Hansen, Karin Holmskov, Chmielewska, Izabela, Forster, Martin D, Giannopoulou, Christina, Stollenwerk, Bjorn, Obiozor, Cynthia C, Wang, Yang, Novello, Silvia

Volltext